Chapman Steven Leonard sold $819K of NTRA
Chapman Steven Leonard (CEO AND PRESIDENT) sold 3,076 shares of Natera, Inc. (NTRA) at an average of $266.40 ($259.98–$268.22, $0.82M total) across 7 trades on 2026-08-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure updates the record of insider activity, but the pre-arranged 10b5-1 structure reduces the likelihood of a new fundamental narrative.
Market read
Traders may monitor insider activity for sentiment, but this specific filing is unlikely to drive a durable repricing without additional company news.
What to watch
The article does not state whether the CEO increased other holdings, sold for tax/option exercises, or whether there were concurrent company-specific catalysts; without that, the trading signal is weak.
Background
This is an SEC Form 4 insider transaction for Natera, Inc., reported by the CEO and President.
Ticker impact
Natera CEO and President Chapman Steven Leonard sold about $819K of NTRA shares via an open-market sale under a 10b5-1 plan.
Likely limited near-term impact; any reaction would be sentiment-driven rather than fundamental.
Form 4 shows a scheduled 10b5-1 sale (not a surprise discretionary sale) and provides no accompanying operational or guidance change.
Market effects
Minimal; insider selling in a single biotech/diagnostics name does not reset sector fundamentals.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may reflect routine liquidity rather than bearish expectations, so any negative read-through could be overdone.
Key entities
- issuerNatera, Inc.
Company whose CEO and President reported an open-market sale of shares on a 10b5-1 plan.
- insiderChapman Steven Leonard
CEO and President who sold 3,076 shares across seven trades on Aug 3, 2026.
